- Date of occurrence of the event: Mar 8, 2019
- Company name: OBI Pharma Inc.
- Relationship to the Company (please enter “head office” or subsidiaries”): Head office
- Reciprocal shareholding ratios: N/A
- Cause of occurrence:
From the 2018 Individual/Consolidated Financial Statement:
Individual Financial Statement:
Operating loss :(1,300,667) thousand dollars
Total comprehensive loss for the period :(1,224,428) thousand dollars
Loss Per Share (in dollars) :( 7.06) dollarsConsolidated Financial Statement:
Operating loss :(1,427,683) thousand dollars
Total comprehensive loss for the period :(1,251,780) thousand dollars
Loss Per Share (in dollars) :( 7.06) dollars - Countermeasures: N/A
- Any other matters that need to be specified: None